Skip to content
Oncology Research Hub

Michigan

Cancer clinical trials in Michigan

390 cancer studies are recruiting participants at sites in 66 cities across Michigan as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Michigan by city

Cities with the most studies recruiting right now.

Every Michigan city with a recruiting study

By research area: Breast Cancer (110), Lung Cancer (106), Lymphoma (70), Prostate Cancer (60), Pancreatic Cancer (26), Melanoma (18).

Detroit (164), Grand Rapids (155), Ann Arbor (145), Brighton (50), Lansing (49), Ypsilanti (47), Flint (46), Livonia (45), Pontiac (45), Chelsea (44), Canton (43), Kalamazoo (41), Traverse City (37), Dearborn (34), Royal Oak (34), Wyoming (33), Novi (30), Saginaw (30), Battle Creek (29), Reed City (29), Saint Joseph (29), Niles (28), Clinton Township (27), Farmington Hills (27), West Bloomfield (27), Tawas City (26), Clarkston (25), Macomb (25), Brownstown (23), Troy (23), Jackson (22), Wyandotte (22), Warren (21), Grosse Pointe Woods (19), Escanaba (17), East China Township (16), Muskegon (16), Norton Shores (16), Southfield (15), Mount Pleasant (12), Lapeer (9), Midland (9), Alma (8), Alpena (8), Gladwin (8), Petoskey (8), Bay City (7), Manistique (7), Port Huron (7), Sterling Heights (7), Mount Clemens (6), Iron Mountain (3), Madison Heights (3), Caro (2), East China (2), Holland (2), Marlette (2), Marquette (2), West Branch (2), Adrian (1), Big Rapids (1), Chesterfield (1), Grayling (1), Grosse Pointe Farms (1), Monroe (1), Plymouth (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Michigan

Basic details from each study's public record (the 12 most recently updated of 390). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    LeonaBio
    Recruiting in
    Grand Rapids
    Registry record
    NCT05696626 · updated
  2. A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Detroit
    Registry record
    NCT05894239 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Michigan on ClinicalTrials.gov.

Lung cancer: recently updated in Michigan

  1. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Ypsilanti
    Registry record
    NCT07513376 · updated
  2. A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Grand Rapids
    Registry record
    NCT07903415 · updated
  3. A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Novelty Nobility, Inc.
    Recruiting in
    Ann Arbor
    Registry record
    NCT06805825 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Michigan on ClinicalTrials.gov.

Prostate cancer: recently updated in Michigan

  1. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Ann Arbor
    Registry record
    NCT04038502 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Michigan on ClinicalTrials.gov.

Melanoma: recently updated in Michigan

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Battle Creek · Grand Rapids · Kalamazoo · and 5 more U.S. locations
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Michigan on ClinicalTrials.gov.

Lymphoma: recently updated in Michigan

  1. Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eastern Cooperative Oncology Group
    Recruiting in
    Detroit · Farmington Hills
    Registry record
    NCT06724237 · updated
  2. Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Grand Rapids
    Registry record
    NCT06806033 · updated
  3. A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Recruiting in
    Detroit
    Registry record
    NCT07221500 · updated
  4. A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Ann Arbor · Detroit · Grand Rapids · and 1 more U.S. location
    Registry record
    NCT06717347 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Michigan on ClinicalTrials.gov.

Ask about studies in Michigan

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call